AN ITALIAN PIONEER IN THE STYDY OF TUMOR ANGIOGENESIS



 
 
Domenico Ribatti, Angelo Vacca, Marco Presta*

 
Department of Human Anatomy and Histology, University of Bari Medical School, Piazza G. Cesare 11, Policlinico di Bari, 70124 Bari, Italy.
*Dept. of Biomedical Sciences and Biotechnology, School of Medicine, University of Brescia, 25123 Brescia, Italy

 

 
 
 
 
 
 


 
 

Back to Presta's lab
 

     
    AN ITALIAN PIONEER IN THE STYDY OF TUMOR ANGIOGENESIS
 
It is generally accepted that the role of angiogenesis in the progression of human solid tumors was originally postulated by Folkman in 1971 (1). The central component in this revolutionary paradigm was that tumor cells undergo an angiogenic switch and generate vascularization intimate to the tumor (2).  Prior to this switch, tumors are less than 3 mm3 and thus this new vascularization allows them to grow rapidly, invade and spread. The switch to an angiogenic phenotype is essentially an outcome of a change in the pro- and anti-angiogenic vascular factors produced by tumor cells, such that the microenvironment is altered and tumor-related microvessels proliferate. Research on tumor angiogenesis, however, was really started by Virchow (3) who recognized that the stroma of tumors has a distinctive capillary network. Many investigators subsequently showed that vessels induced by tumor are different from normal vessels (4). The growth of these vessels is related to that of the tumor and they may thus be targets for therapy (5). Tumor vascularization was first studied systematically by Goldmann (6), who described the vasoproliferative response of the organ in which a tumor develops as follows: "The normal blood vessels of the organs in which the tumor is developing are disturbed by chaotic growth, there is a dilatation and spiralling of the affected vessels, marked capillary budding and new vessel formation, particularly at the advancing border". 
When Clark et al. (7,8) perfected the implantation of transparent chambers in a rabbit's ear, the morphologic characteristics of blood vessels could be studied in vivo, including the use of contrast media. In 1939 Ide et al.9 were the first to suggest that tumors release specific factors that stimulate the growth of blood vessels, while in 1945 Algire and Chalkley (10) used a transparent chamber implanted in the skin of a cat to study the vasoproliferative reaction secondary to a wound or implantation of normal or neoplastic tissues and showed that the vasoproliferative response induced by tumor tissues was more substantial and earlier than that induced by normal tissues or following a wound. They concluded that the growth of a tumor is closely connected to the development of an intrinsic vascular network. In his treatise Il Cancro, published by Ambrosiana in 1946 (11), Pietro Rondoni, Professor of General Pathology at the University of Milan, and Director of the Milan Cancer Institute, stated with regard to the stroma of tumors that: "a tumor acts both angioplastically and angiotactically, in other words it promotes the formation of new vessels and attracts vascular outgrowths (capillaries and pluripotent perivasal cells) so as to build up and shape a stroma of its own, a newly formed stroma. It must thus be unreservedly admitted that tumors are partly vascularized by the already existing network of vessels around them. As in other pathological processes, therefore, such neoformation as takes place is a vascular neoformation from budding of the existing capillaries". 

The importance of this passage lies in the fact that Rondoni refers to the ability of a tumor to induce the formation of new blood vessels from those that already surround it. He also asserts that this angiogenic activityoccurs in its stroma. 

Harold Dvorak in 1986 (12) first highlighted the role played by the stromal component in tumor progression and proposed a similarity between tumors and wounds by defining cancer as a wound that does not heal. Subsequent research has demonstrated that the tumor microenvironment plays an active role through adhesion molecules, angiogenesis and stromal host cells. The peritumoral inflammatory infiltrate surrounding newly formed blood vessels consists of fibroblasts, macrophages, mast cells and other leukocytes that may contribute to the induction of an angiogenic response by secreting angiogenic cytokines and proteolytic enzymes which, in turn, mobilize angiogenic factors stored in the extracellular matrix (13). 

The topicality of Rondoni's remarks is evident. More than 50 years ago, he was speaking of both the angiogenic capacity of a tumor and the importance of the stroma in new vessel formation. The concept of a microenvironment within which angiogenesis occurs is particularly topical. This context, indeed, appears to govern the time and space patterns of angiogenesis. It also determines whether it will remain confined within physiologic bounds or progress to a pathologic state, and is thus a therapeutic target through which normality may be restored. 
 

--------------------------------------------------------------------------------
References

1) Ribatti D, Vacca A, Dammacco F. The role of the vascular phase in solid tumor growth: a historical review. Neoplasia 1999; 1:293-302. 
2) Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86:353-64. 
3) Virchow R. Die Krankhaften Geschwulste. August Hirschwald Editor; Berlin. 1863. 
4) Dvorak HF, Nagy JA, Dvorak AM. Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. Cancer Cells 1991; 3:77-85. 
5) Burrows FJ, Thorpe PE. Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. Proc Natl Acad Sci USA 1993; 90:8996-9000. 
6) Goldman E. The growth of malignant disease in man and the lower animals with special reference to the vascular system. Lancet 1907; 2:1236-40. 
7) Clark ER, Hitschler WJ, Kirby-Smith HT, Rex RO, Smith JH. General observations on the ingrowth of new blood vessels into standardized chambers in the rabbit's ear, and the subsequent changes in the newly grown vessels over a period of months. Anat Rec 1931; 50:129-67. 
8) Clark ER, Clark EI. Microscopic observations on the growth of blood capillaries in the living mammals. Am J Anat 1939; 64:251-301. 
9) Ide AG, Baker NH, Warren. Vascularization of the Brown-Pearce rabbit epithelioma transplant as seen in the transparent ear chamber. Am J Roentgenol 1939; 32:891-9. 
10) Algire GH, Chalkley HW. Vascular reactions of normal and malignant tissue in vivo. J Natl Cancer Inst 1945; 6:73-85. 
11) Rondoni P. Il cancro. Casa Editrice Ambrosiana; Milano. 1946. 
12) Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315:1650-9. 
13) Folkman J, Brem H. Angiogenesis and inflammation. In: Gallin J, Goldstein M, Synderman E, editors. Inflammation: Basic Principles and Clinical Applications. New York: Raven Press; 1992. p. 821-39.

Haematologica, 86: 1234-1235 (2001)

AIRC: Special Project Angiogenesis